Menu

• Ask a Health Expert about INFUSION SITE BRUISING
• Post Your Side Effect related to INFUSION SITE BRUISING
• INFUSION SITE BRUISING and FDA Warnings
• INFUSION SITE BRUISING in Patients Wiki
• Report INFUSION SITE BRUISING in Drug Side Effect Survey

INFUSION SITE BRUISING side effect

What is INFUSION SITE BRUISING ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Byetta Side Effects Report #5440888-9
Consumer or non-health professional from UNITED STATES reported BYETTA problem on June 06, 2007. Female patient, 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: infusion site bruising, injection site haemorrhage, injection site joint redness, injection site pruritus, injection site swelling, urticaria, . BYETTA dosage: unknown. During the same period patient was treated with GLYBURIDE, METFORMIN. Patient recovered.

Byetta Side Effects Report #5440888-9
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Female patient, 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: infusion site bruising, injection site haemorrhage, injection site joint redness, injection site pruritus, injection site swelling, urticaria, . BYETTA dosage: unknown. During the same period patient was treated with GLYBURIDE, METFORMIN. Patient recovered.

Ancef Side Effects Report #5266006-8
Health Professional from UNITED STATES reported ANCEF problem on Mar 12, 2007. Female patient, 25 years of age, weighting 230.0 lb, was diagnosed with urinary tract infection and was treated with ANCEF. After drug was administered, patient experienced the following problems/side effects: infusion site bruising, infusion site erythema, oedema peripheral, . ANCEF dosage: unknown. Patient recovered.

Amiodarone Side Effects Report #5268701-3
AMIODARONE problem was reported by a Pharmacist from UNITED KINGDOM on Feb 27, 2007. Male patient, 84 years of age, was diagnosed with atrial fibrillation and was treated with AMIODARONE. After drug was administered, patient experienced the following problems/side effects: infusion site bruising, infusion site extravasation, infusion site pain, . AMIODARONE dosage: 900 MG FREQ UNK IV. Patient recovered.


Reclast Side Effects Report #5802917-X
Physician from UNITED STATES reported RECLAST problem on Feb 18, 2008. Female patient, 60 years of age, was diagnosed with osteoporosis and was treated with RECLAST. After drug was administered, patient experienced the following problems/side effects: back pain, infusion site bruising, myalgia, tenderness, wheezing, . RECLAST dosage: 5 MG, ONCE PER YEAR, INTRAVENOUS. During the same period patient was treated with CELEBREX, DOXYCYCLINE, LIPITOR. Patient recovered.

Penicillin Side Effects Report #5311887-2
PENICILLIN G problem was reported by a Physician from UNITED STATES on Apr 26, 2007. Female patient, 38 years of age, weighting 120.0 lb, was diagnosed with animal bite and was treated with PENICILLIN G. After drug was administered, patient experienced the following problems/side effects: decreased activity, infusion site bruising, injection site phlebitis, pain, . PENICILLIN G dosage: I THINK 2 MILLION UNITS Q4 IV DRIP. During the same period patient was treated with OXYCODONE, ZOFRAN. Patient recovered.

Vivaglobin Side Effects Report #5674540-1
Physician from UNITED KINGDOM reported VIVAGLOBIN problem on Mar 04, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with VIVAGLOBIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, erysipelas, infusion site bruising, infusion site erythema, infusion site rash, injection site reaction, local reaction, migraine, rash erythematous, . VIVAGLOBIN dosage: 114 ML Q1W SC, 114 ML Q1W SC, 114 ML Q1W SC. During the same period patient was treated with PHYLLOCONTIN, QVAR, SEREVENT, ATROVENT, SALBUTAMOL, QUININE SULPHATE. Patient recovered.

Vivaglobin Side Effects Report #5625210-7
VIVAGLOBIN problem was reported by a Physician from UNITED KINGDOM on Jan 17, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with VIVAGLOBIN. After drug was administered, patient experienced the following problems/side effects: erysipelas, infusion related reaction, infusion site bruising, infusion site rash, injection site erythema, injection site swelling, local reaction, migraine, rash erythematous, . VIVAGLOBIN dosage: 114 ML Q1W; SC. During the same period patient was treated with PHYLLOCONTIN, QVAR, SEREVENT, ATROVENT, ALBUTEROL. Patient recovered.